Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27294075)

Published in Int J Transl Sci on January 01, 2016

Authors

Pravin J Mishra1, Prasun J Mishra2, Debabrata Banerjee3

Author Affiliations

1: Intermountain Precision Genomics, Intermountain Healthcare, Dixie Regional Medical Center 292 South 1470 East, Suite 201 & 301, St. George, UT 84770, USA.
2: Department of Biochemical and Cellular Pharmacology, Genentech, 1, DNA Way, South San Francisco, California 94080, USA.
3: Department of Pharmacology, Robert Wood Johnson Medical School, Graduate School of Biomedical Sciences, New Brunswick-Piscataway, Rutgers University, 675 Hoes Lane West, Piscataway, NJ 08854. USA.

Articles cited by this

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Cutaneous wound healing. N Engl J Med (1999) 19.12

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest (2007) 6.56

Formation and function of the myofibroblast during tissue repair. J Invest Dermatol (2007) 6.11

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82

Wound healing and its impairment in the diabetic foot. Lancet (2005) 5.63

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol (2007) 5.60

Regenerating the heart. Nat Biotechnol (2005) 5.58

Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res (2008) 3.97

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol (2007) 3.87

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol (2008) 3.67

Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol (2007) 3.51

Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med (2007) 3.02

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood (2004) 2.90

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood (2007) 2.55

Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg (2005) 2.51

Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol (2003) 2.43

Wound measurement. Int J Dermatol (1996) 2.38

Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery (2003) 2.16

Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells (2004) 2.12

Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol (2003) 2.09

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res (2005) 1.79

Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol (1994) 1.77

Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol (2003) 1.62

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells (2006) 1.56

Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev (2007) 1.49

Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost (2003) 1.41

Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39

Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc (2006) 1.39

Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37

Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) (2004) 1.37

Abnormal wound healing: keloids. Clin Dermatol (2007) 1.35

Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury. Wound Repair Regen (2006) 1.28

Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol (2006) 1.26

Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res (2006) 1.21

In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res (2007) 1.20

Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care (2004) 1.16

The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol (2008) 1.14

Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen (2005) 1.09

A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res (2008) 1.05

Contraction of fibrillar type I collagen by endothelial cells: a study in vitro. J Cell Biochem (1996) 1.05

Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int (2005) 1.05

The cellular derivation and the life span of the myofibroblast. Pathol Res Pract (1996) 1.03

Chemokines and diabetic wound healing. Vascular (2007) 1.03

Venous and arterial leg ulcers. BMJ (2006) 0.98

Decubitus ulcers: a review of the literature. Int J Dermatol (2005) 0.96

Dense fibrillar collagen matrices: a model to study myofibroblast behaviour during wound healing. Biomaterials (2006) 0.92

Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium. Arthritis Rheum (2008) 0.92

An improved method for the collagen gel contraction assay. In Vitro Cell Dev Biol Anim (2002) 0.92

Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res (1994) 0.91

Old age, malnutrition, and pressure sores: an ill-fated alliance. J Gerontol A Biol Sci Med Sci (2004) 0.91

Three-dimensional epidermis-like growth of human mesenchymal stem cells on dermal equivalents: contribution to tissue organization by adaptation of myofibroblastic phenotype and function. Differentiation (2007) 0.89

Cell-free derivatives from mesenchymal stem cells are effective in wound therapy. World J Stem Cells (2012) 0.84